1-11 of 11
Anthony C. Keech
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Meeting Abstracts

1350-P: Risk Models for the Development of Cardiovascular and Microvascular Events in Adults with Type 2 Diabetes in the FIELD Study

KWOK LEUNG ONG, RACHEL L. O'CONNELL, ANDRZEJ S. JANUSZEWSKI, MARK W. DONOGHOE, VAL GEBSKI, DAVID SULLIVAN, KERRY ANN RYE, RUSSELL S. SCOTT, JAMES D. BEST, MARJA-RIITTA TASKINEN, ROBERT J. SIMES, ALICIA JENKINS, ANTHONY C. KEECH
Journal: Diabetes
Diabetes 2023;72(Supplement_1):1350-P
https://doi.org/10.2337/db23-1350-P
Published: 20 June 2023
View article titled, 1350-P: Risk Models for the Development of Cardiovascular and Microvascular Events in Adults with Type 2 Diabetes in the FIELD Study
Meeting Abstracts

699-P: Prerandomization Factors Associated with Time-in-Target Glucose Range with Hybrid Closed-Loop Use in a Six-Month Randomized Controlled Trial in Adults with Type 1 Diabetes

ALICIA JENKINS, ANDRZEJ S. JANUSZEWSKI, ADRIENNE KIRBY, SYBIL A. MCAULEY, MELISSA H. LEE, BARBORA PALDUS, SARA VOGRIN, MARTIN DE BOCK, MORTON BURT, NEALE COHEN, PETER G. COLMAN, ELIZABETH A. DAVIS, JANE HOLMES-WALKER, ANTHONY C. KEECH, RICHARD MACISAAC, CATRIONA M. SIMS, VIJAYA SUNDARARAJAN, STEVEN TRAWLEY, GLENN M. WARD, TIM JONES, DAVID N. O’NEAL, JDRF AUSTRALIA ADULT HYBRID CLOSED LOOP TRIA
Journal: Diabetes
Diabetes 2021;70(Supplement_1):699-P
https://doi.org/10.2337/db21-699-P
Published: 01 June 2021
View article titled, 699-P: Prerandomization Factors Associated with Time-in-Target Glucose Range with Hybrid Closed-Loop Use in a Six-Month Randomized Controlled Trial in Adults with Type 1 Diabetes
Meeting Abstracts

999-P: Six Months At-Home Hybrid Closed-Loop vs. Manual Insulin Delivery with Finger-Stick Blood Glucose Monitoring in Adults with Type 1 Diabetes: A Randomized Controlled Trial

SYBIL A. MCAULEY, MELISSA H. LEE, BARBORA PALDUS, SARA VOGRIN, MARY B. ABRAHAM, LEON BACH, MORTON BURT, NEALE COHEN, PETER G. COLMAN, ELIZABETH A. DAVIS, CHRISTEL HENDRIECKX, MARTIN DE BOCK, JANE HOLMES-WALKER, JOEY KAYE, KAVITA KUMARESWARAN, RICHARD MACISAAC, ROLAND W. MCCALLUM, CATRIONA M. SIMS, JANE SPEIGHT, STEPHEN STRANKS, STEVEN TRAWLEY, VIJAYA SUNDARARAJAN, GLENN WARD, ANTHONY C. KEECH, ALICIA JENKINS, TIM JONES, DAVID N. ONEAL
Journal: Diabetes
Diabetes 2020;69(Supplement_1):999-P
https://doi.org/10.2337/db20-999-P
Published: 01 June 2020
View article titled, 999-P: Six Months At-Home Hybrid Closed-Loop vs. Manual Insulin Delivery with Finger-Stick Blood Glucose Monitoring in Adults with Type 1 Diabetes: A Randomized Controlled Trial
Meeting Abstracts

274-OR: Effect of Testosterone Treatment on Type 2 Diabetes Incidence in High-Risk Men Enrolled in a Lifestyle Program: A Two-Year Randomized Placebo-Controlled Trial

GARY A. WITTERT, KRISTY P. ROBLEDO, MATHIS GROSSMANN, KAREN BRACKEN, BU B. YEAP, BRONWYN G.A. STUCKEY, ROBERT I. MCLACHLAN, DAVID J. HANDELSMAN, CAROLYN ALLAN, WARRICK INDER, DAVID JESUDASON, ANTHONY C. KEECH, ALICIA JENKINS, MARK NG TANG FUI, MARK DANIEL
Journal: Diabetes
Diabetes 2020;69(Supplement_1):274-OR
https://doi.org/10.2337/db20-274-OR
Published: 01 June 2020
View article titled, 274-OR: Effect of Testosterone Treatment on Type 2 Diabetes Incidence in High-Risk Men Enrolled in a Lifestyle Program: A Two-Year Randomized Placebo-Controlled Trial
Meeting Abstracts

23-LB: Lipoprotein Subfractions Are Associated with Diabetic Cardiovascular Disease and Death among 9,795 Patients in the FIELD Trial

STEVEN R. JONES, ALICIA J. JENKINS, ANDRZEJ S. JANUSZEWSKI, RACHEL L. OCONNELL, LIPING LI, DAVID SULLIVAN, MARJA-RIITTA TASKINEN, RUSSELL SCOTT, GERALD FRANCIS WATTS, PHILIP J. BARTER, R. JOHN SIMES, PETER P. TOTH, ANTHONY C. KEECH
Journal: Diabetes
Diabetes 2019;68(Supplement_1):23-LB
https://doi.org/10.2337/db19-23-LB
Published: 01 June 2019
View article titled, 23-LB: Lipoprotein Subfractions Are Associated with Diabetic Cardiovascular Disease and Death among 9,795 Patients in the FIELD Trial
Meeting Abstracts

41-LB: Lipoprotein Subfractions Are Associated with Diabetic Microvascular Disease among 9,795 Patients in the FIELD Trial

PETER P. TOTH, ANTHONY C. KEECH, ANDRZEJ S. JANUSZEWSKI, RACHEL L. OCONNELL, LIPING LI, DAVID SULLIVAN, MARJA-RIITTA TASKINEN, PAUL L. DRURY, ESQ., GERALD FRANCIS WATTS, JAMES D. BEST, JEAN CLAUDE ANSQUER, STEVEN R. JONES, ALICIA J. JENKINS
Journal: Diabetes
Diabetes 2019;68(Supplement_1):41-LB
https://doi.org/10.2337/db19-41-LB
Published: 01 June 2019
View article titled, 41-LB: Lipoprotein Subfractions Are Associated with Diabetic Microvascular Disease among 9,795 Patients in the FIELD Trial
Meeting Abstracts

139-LB: Haptoglobin Phenotype and Levels in Type 2 Diabetes and Effects of Fenofibrate

ANDRZEJ S. JANUSZEWSKI, HAYDEN K. YOUNG, LIPING LI, RACHEL L. OCONNELL, TIMOTHY LYONS, CLARE B. KELLY, DAVID SULLIVAN, RUSSELL SCOTT, ANTHONY C. KEECH, ALICIA JENKINS
Journal: Diabetes
Diabetes 2019;68(Supplement_1):139-LB
https://doi.org/10.2337/db19-139-LB
Published: 01 June 2019
View article titled, 139-LB: Haptoglobin Phenotype and Levels in Type 2 Diabetes and Effects of Fenofibrate
Meeting Abstracts

22-LB: Baseline and Short-Term Change in Plasma Uric Acid on Fenofibrate Predict Cardiovascular Risk: A Post Hoc Analysis of FIELD

JACOB YIMING CAO, BORIS WALDMAN, RACHEL L. OCONNELL, DAVID SULLIVAN, VAL GEBSKI, ANDRZEJ S. JANUSZEWSKI, IAN MARSCHNER, RUSSELL SCOTT, MARJA-RIITTA TASKINEN, R. JOHN SIMES, NEIL MCGILL, ALICIA J. JENKINS, ANTHONY C. KEECH
Journal: Diabetes
Diabetes 2019;68(Supplement_1):22-LB
https://doi.org/10.2337/db19-22-LB
Published: 01 June 2019
View article titled, 22-LB: Baseline and Short-Term Change in Plasma Uric Acid on Fenofibrate Predict Cardiovascular Risk: A Post Hoc Analysis of FIELD
Journal Articles

Fenofibrate Rescues Diabetes-Related Impairment of Ischemia-Mediated Angiogenesis by PPARα-Independent Modulation of Thioredoxin-Interacting Protein

Jun Yuan, Joanne T.M. Tan, Kushwin Rajamani, Emma L. Solly, Emily J. King, Laura Lecce, Philippa J.L. Simpson, Yuen Ting Lam, Alicia J. Jenkins, Christina A. Bursill, Anthony C. Keech, Martin K.C. Ng
Journal: Diabetes
Diabetes 2019;68(5):1040–1053
https://doi.org/10.2337/db17-0926
Published: 14 February 2019
View article titled, Fenofibrate Rescues Diabetes-Related Impairment of Ischemia-Mediated Angiogenesis by PPARα-Independent Modulation of Thioredoxin-Interacting Protein
Open the PDF for Fenofibrate Rescues Diabetes-Related Impairment of Ischemia-Mediated Angiogenesis by PPARα-Independent Modulation of Thioredoxin-Interacting Protein in another window
Includes: Supplementary data
Journal Articles

An Update on the Molecular Actions of Fenofibrate and Its Clinical Effects on Diabetic Retinopathy and Other Microvascular End Points in Patients With Diabetes

Jonathan E. Noonan, Alicia J. Jenkins, Jian-Xing Ma, Anthony C. Keech, Jie Jin Wang, Ecosse L. Lamoureux
Journal: Diabetes
Diabetes 2013;62(12):3968–3975
https://doi.org/10.2337/db13-0800
Published: 16 November 2013
View article titled, An Update on the Molecular Actions of Fenofibrate and Its Clinical Effects on Diabetic Retinopathy and Other Microvascular End Points in Patients With Diabetes
Open the PDF for An Update on the Molecular Actions of Fenofibrate and Its Clinical Effects on Diabetic Retinopathy and Other Microvascular End Points in Patients With Diabetes in another window
Journal Articles

Therapeutic Effects of PPARα Agonists on Diabetic Retinopathy in Type 1 Diabetes Models

Ying Chen, Yang Hu, Mingkai Lin, Alicia J. Jenkins, Anthony C. Keech, Robert Mott, Timothy J. Lyons, Jian-xing Ma
Journal: Diabetes
Diabetes 2013;62(1):261–272
https://doi.org/10.2337/db11-0413
Published: 13 December 2012
View article titled, Therapeutic Effects of PPARα Agonists on Diabetic Retinopathy in Type 1 Diabetes Models
Open the PDF for Therapeutic Effects of PPARα Agonists on Diabetic Retinopathy in Type 1 Diabetes Models in another window
Includes: Supplementary data